Cognitive impairment in survivors of prostate cancer: combining cognitive and physical activity to target brain fog
- Conditions
- Cancer related cognitive impairementCancer - ProstateMental Health - Studies of normal psychology, cognitive function and behaviour
- Registration Number
- ACTRN12623000767606
- Lead Sponsor
- niversity of Canberra
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 76
Participants eligible to participate must meet the following inclusion criteria: male >18 years old, diagnosed with prostate cancer currently receiving primary ADT for both metastatic and non-metastatic hormone-sensitive prostate cancer. Further inclusion criteria includes having had at least one dose of ADT in the last six months prior to enrolment; self-assessed reading and writing English proficiency, able to provide written informed consent and who have expected life expectancy of more than 12 months.
-self-assessed reading and writing English proficiency, able to provide written informed consent and who have expected life expectancy of more than 12 months.
Based on known interactions with the primary outcome measures, participants will be excluded if they have received chemotherapy or radiation within the last 3 months; they are on steroids equivalent to more than 10 mg of prednisolone a day; opioid-based analgesics within the last 28 days; previous neurological injury; major depression; or are unable to provide written informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method